Almac Adapt is a Just In Time Manufacturing solution which puts patients first and provides sponsors with a unique, adaptive supply strategy to ultimately meet the expanding challenges of clinical trials.
As your clinical material partner, we simplify – and accelerate – your clinical trials. From assistance with time-consuming international documentation through destruction following all regulatory protocols, RPS is your trusted clinical trial partner.
Ropack Pharma Solutions is positioned to warehouse and distribute even the most sensitive products.
Ropack Pharma Solutions provides a serialized supply chain that is proficient, verified and ready to safeguard your pharmaceutical product and the patients who depend on it.
Ropack Pharma Solutions is equipped to produce sachets in a range of fills, including powder, liquid/cream and solid dosage fill of one or two different products per sachet.
With ample available capacity, Ropack Pharma Solutions provides the efficiency of five bottling lines with quick changeovers, online validated fill accuracy and the flexibility to accommodate small lots to commercial runs for the bottling of tablets, capsules and powders.
The blending of APIs and excipients to create a homogenous blend is a crucial component in the solid dose and powder dose pharmaceutical manufacturing process. Because blender speed and time are key factors in achieving a uniform mixture, Ropack utilizes gold-standard technology.
Ropack Pharma Solution’s ample, nimble capacity and validated processes bring quality and reliability to encapsulation.
UBC has focused on drug safety evaluation with RWD for more than 15 years and is aligned with FDA’s Sentinel Initiative. UBC’s safety scientists and epidemiologists provide comprehensive and customized RWD solutions to evaluate the safety of your marketed products.
Implementing an enterprise-wide Real World Evidence strategy is essential to meet the growing demands of regulators, patients, healthcare providers and payers to support approval, treatment decisions and reimbursement. Fluency in evidence-generation combined with operational expertise in RWE are crucial for capitalizing on the potential RWE has to offer.
|
|
|
|
|
|
|
|
|